David Charles Link - Jul 15, 2024 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
Director
Signature
/s/ David Charles Link
Stock symbol
SABS
Transactions as of
Jul 15, 2024
Transactions value $
$0
Form type
4
Date filed
7/17/2024, 04:30 PM
Previous filing
Dec 9, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SABS Stock Option (right to buy) Award $0 +20K $0.00 20K Jul 15, 2024 Common Stock 20K $2.90 Direct F1, F3
transaction SABS Stock Option (right to buy) Award $0 +9.31K $0.00 9.31K Jul 15, 2024 Common Stock 9.31K $2.90 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the 2024 annual grant to the Reporting Person as a member of the Board of Directors of the Issuer (the "Board"). Shares underlying the option vest in two equal annual installments on July 15, 2025, and 2026.
F2 Represents a one-time grant to the Reporting Person as a member of the Board. Shares underlying the option vest in three equal annual installments on July 15, 2025, 2026, and 2027.
F3 This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended.